The company's financial stability appears fragile, with total assets contracting to $10.2 million and an equity base that has historically struggled with volatility, including a period of negative equity in 2024Q4.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 |
|---|
| Total Current Assets | 9.16M | 5.44M | 4.59M | 10.3M | 9.91M | 29.94M | 8.94M | 10.11M | 8.72M | 13.94M | 5.72M | 10.5M | 13.02M | 24.99M | 24.4M | 31.57M | 37.8M | 15.1M | 26.79M | 57.55M | 34.96M | 10.88M |
| Cash & Short-Term Investments | 8.8M | 4.98M | 693K | 4.56M | 3.96M | 22.77M | 3.01M | 2.94M | 5.55M | 10.16M | 3.31M | 7.93M | 11.62M | 23.3M | 22.31M | 29.49M | 30.84M | 14.62M | 26.3M | 57.03M | 34.73M | 10.72M |
| Cash Only | 8.8M | 4.98M | 693K | 4.56M | 3.96M | 22.77M | 3.01M | 2.94M | 5.55M | 10.16M | 3.31M | 7.93M | 11.62M | 23.3M | 22.31M | 28.49M | 30.84M | 14.62M | 21.06M | 48.73M | 17.54M | 10.72M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23.29M | 2.5M | 0 | 0 | 0 | 0 | 1.01M | 0 | 0 | 5.24M | 8.3M | 17.2M | 0 |
| Accounts Receivable | 140.84K | 98.61K | 1.03M | 1.66M | 2.18M | 2.81M | 2.62M | 4.1M | 917K | 488.61K | 143.69K | 57.93K | 2.81K | 0 | 52.41K | 0 | 0 | 10.01K | 77.27K | 96.31K | 155.52K | 21.6K |
| Days Sales Outstanding | 75.15 | 112.58 | 46.87 | 69.78 | 70.79 | 75.55 | 84.64 | 99.08 | 551.67 | 138.56 | 66.67 | 72.41 | - | - | 61.31 | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 2.46M | 3.74M | 3.61M | 3M | 2.24M | 1.32M | 984.74K | 2.82M | 1.79M | 1.69M | 981K | 1.13M | 1.27M | 1.07M | 0 | -14.14M | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | 334.05 | - | 304.48 | 436.25 | 296.98 | 208.7 | 162.61 | 83.11 | 2.19K | 1.1K | 1.51K | 4.92K | - | - | 2K | - | - | - | - | - | - | - |
| Other Current Assets | 15.17K | 357.38K | 114K | 126K | 84K | 238K | 159K | 215K | 147K | 848.57K | 319 | -987 | -171 | 0 | 200K | 200K | 6.53M | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | 1.02M | 1.06M | 205K | 431K | 1.35M | 22.59M | 30.77M | 29.55M | 37.55M | 74.77M | 1.32M | 1.08M | 1.36M | 1.4M | 1.69M | 919.33K | 882K | 1.11M | 1.48M | 1.5M | 1.11M | 679.11K |
| Property, Plant & Equipment | 65.67K | 75.82K | 154K | 310K | 869K | 1.72M | 1.05M | 774K | 63.55K | 439K | 201K | 326K | 482K | 577K | 610K | 630.35K | 742K | 966K | 1.26M | 1.49M | 1.1M | 642.55K |
| Fixed Asset Turnover | 15.94x | 4.22x | 51.99x | 27.99x | 12.93x | 7.91x | 10.77x | 19.49x | 9.55x | 2.93x | 3.91x | 0.90x | - | - | 0.51x | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 27.19M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 314.19K | 314.19K | 0 | 0 | 260K | 20.83M | 27.02M | 28.67M | 36.93M | 46.15M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 601.54K | 601.54K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 643K | 67.31K | 29K | 29K | 46K | 46K | 46K | 99K | 562.86K | 989K | 1.12M | 759K | 880K | 822K | 1.08M | 288.98K | 140K | 146K | 220.91K | 5K | 6.39K | 36.56K |
| Total Assets | 10.19M | 6.5M | 4.79M | 10.73M | 11.27M | 52.53M | 39.71M | 39.66M | 46.27M | 88.7M | 7.04M | 11.59M | 14.39M | 26.39M | 26.1M | 32.49M | 38.69M | 16.21M | 28.28M | 59.05M | 36.06M | 11.56M |
| Asset Turnover | 0.16x | 0.05x | 1.67x | 0.81x | 1.00x | 0.26x | 0.28x | 0.38x | 0.01x | 0.01x | 0.11x | 0.03x | - | - | 0.01x | - | - | - | - | - | - | - |
| Asset Growth % | 159.36% | 35.56% | -55.32% | -4.78% | -78.56% | 32.27% | 0.15% | -14.3% | -47.84% | 1159.84% | -39.23% | -19.46% | -45.48% | 1.12% | -19.67% | -16.03% | 138.6% | -42.66% | -52.11% | 63.74% | 211.95% | - |
| Total Current Liabilities | 2.14M | 2.74M | 4.99M | 3.78M | 7.48M | 7.53M | 11.61M | 10.39M | 8.36M | 1.09M | 1.31M | 4.49M | 3.38M | 127K | 7.54M | 9.56M | 6.03M | 34K | 5.88M | 7.75M | 5.03M | 2.24M |
| Accounts Payable | 532.13K | 647.53K | 2.21M | 1.69M | 1.93M | 3.47M | 3.65M | 4.26M | 1.63M | 1.09M | 1.31M | 172.05K | 399.34K | 127.33K | 340.56K | 434.44K | 125.19K | 33.62K | 163.38K | 300.34K | 678.76K | 316.85K |
| Days Payables Outstanding | 547.16 | 2.09K | 273.29 | 196.96 | 158.4 | 241.02 | 264.86 | 269.02 | 3.61K | 424.2 | 1.11K | 502.39 | - | - | 535.79 | - | - | - | - | - | - | - |
| Short-Term Debt | 22.55K | 31.26K | 811K | 111K | 171K | 0 | 3.92M | 1.91M | 9.93M | 1.96M | 0 | 717.39K | 2.98M | 4M | 3M | 2.31M | 922K | 3.88M | 2.67M | 5.08M | 2.65M | 998.05K |
| Deferred Revenue (Current) | 24.84K | 0 | 720K | 0 | 0 | 549K | 0 | 0 | 352K | 510K | 0 | -549.56K | -4.35M | -8.71M | -445 | 0 | -2.95M | -6.25M | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 972.41K | 2.06M | 207K | 1.22M | 3.44M | 600K | 2.03M | 1.39M | -6.88M | -1.01M | -2.24M | 0 | -4.35M | -8.71M | 0 | 0 | 0 | -6.25M | 0 | 0 | 0 | 0 |
| Current Ratio | 4.27x | 1.99x | 0.92x | 2.73x | 1.32x | 3.98x | 0.77x | 0.97x | 1.04x | 12.81x | 4.36x | 2.34x | 3.86x | 196.76x | 3.24x | 3.30x | 6.27x | 444.18x | 4.56x | 7.42x | 6.94x | 4.85x |
| Quick Ratio | 4.27x | 1.99x | 0.43x | 1.74x | 0.84x | 3.58x | 0.58x | 0.85x | 0.92x | 10.22x | 3.00x | 1.97x | 3.57x | 187.88x | 3.07x | 3.19x | 6.27x | 860.16x | 4.56x | 7.42x | 6.94x | 4.85x |
| Cash Conversion Cycle | -137.96 | - | 78.06 | 309.07 | 209.37 | 43.23 | -17.61 | -86.83 | -875.16 | 812.41 | 471.28 | 4.49K | - | - | 1.53K | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 0 | 61K | 287K | 123K | 667K | 13.62M | 5.16M | 6.25M | 11.25M | 2.79M | 3.43M | 4.35M | 11.58M | 6.68M | 2.88M | 2.95M | 10.6M | 11M | 6.02M | 2.46M | 7.34M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 9.17M | 2.73M | 0 | 7.96M | 9.88M | 549.79K | 0 | 2.87M | 6.68M | 2.88M | 4.98M | 3.88M | 11M | 6.02M | 1.73M | 7.34M |
| Capital Lease Obligations | 8.15K | 0 | 41K | 151K | 0 | 0 | 163K | 477K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 64K | 123K | 367K | 3.27M | 0 | 1.84M | 5.29M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 20K | 72K | 0 | 300K | 1.02M | 1.96M | 6.25M | -2.67M | -9.84M | 2.88M | 0 | 8.71M | 0 | 0 | -2.03M | 6.72M | 0 | 0 | 728.84K | 0 |
| Total Liabilities | 2.14M | 2.74M | 5.05M | 4.06M | 7.6M | 8.2M | 25.23M | 15.55M | 14.61M | 12.34M | 4.1M | 7.91M | 7.72M | 11.71M | 14.22M | 12.44M | 8.98M | 10.63M | 16.87M | 13.77M | 7.49M | 9.59M |
| Total Debt | 22.55K | 31.26K | 967K | 262K | 171K | 279K | 13.25M | 5.41M | 6.31M | 488.61K | 143.69K | 1.27M | 2.98M | 6.87M | 9.68M | 5.19M | 5.91M | 7.76M | 13.67M | 11.1M | 4.38M | 8.34M |
| Net Debt | -8.77M | -4.95M | 274K | -4.3M | -3.78M | -22.49M | 10.25M | 2.47M | 762.47K | -9.67M | -3.17M | -6.66M | -8.64M | -16.43M | -12.63M | -23.3M | -24.94M | -6.86M | -7.38M | -37.63M | -13.16M | -2.38M |
| Debt / Equity | 0.00x | 0.01x | - | 0.04x | 0.05x | 0.01x | 0.91x | 0.22x | 0.20x | 0.01x | 0.05x | 0.34x | 0.45x | 0.47x | 0.82x | 0.26x | 0.20x | 1.39x | 1.20x | 0.25x | 0.15x | 4.22x |
| Debt / EBITDA | -0.00x | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | 1.63x | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -140.78x | -18.73x | - | - | -411.34x | -75.23x | -9.64x | -165.52x | -3096.17x | -8460.54x | -4.87x | -29.67x | -48.27x | -26.53x | -25.01x | -33.98x | -12.78x | -6.78x | -12.52x | -16.27x | -24.51x | -60.52x |
| Total Equity | 8.04M | 3.76M | -253K | 6.66M | 3.66M | 44.33M | 14.49M | 24.11M | 31.66M | 76.37M | 2.94M | 3.67M | 6.66M | 14.68M | 11.88M | 20.04M | 29.71M | 5.58M | 11.41M | 45.28M | 28.57M | 1.97M |
| Equity Growth % | 2396.3% | 1586.96% | -103.8% | 82% | -91.74% | 206% | -39.9% | -23.86% | -58.54% | 2498.4% | -19.98% | -44.88% | -54.6% | 23.61% | -40.75% | -32.54% | 432.29% | -51.07% | -74.81% | 58.47% | 1347.1% | - |
| Book Value per Share | 1.36 | 1.74 | -12.27 | 1622.35 | 12508.42 | 294177.70 | 336930.23 | 999999.00 | 999999.00 | 999999.00 | 0.18 | 478270.15 | 867735.45 | 0.23 | 871.03 | 1924.11 | 10232.17 | 3253.70 | 1964.58 | 53708.14 | 160139.03 | 14716.53 |
| Total Shareholders' Equity | 6.74M | 2.44M | -253K | 6.66M | 3.66M | 44.33M | 14.49M | 24.11M | 31.66M | 76.37M | 2.94M | 3.67M | 6.66M | 14.68M | 11.88M | 20.04M | 29.71M | 5.58M | 11.41M | 45.28M | 28.57M | 1.97M |
| Common Stock | 7.02K | 5.92K | 0 | 23K | 1K | 0 | 4K | 0 | 87.7K | 309.57K | 27.37K | 71.64K | 695.7K | 635.51K | 418.43K | 367.53K | 278.92K | 373.78K | 169K | 167.99K | 5.8K | 4.8K |
| Retained Earnings | -88.53M | -87.56M | -642.7M | -635.57M | -624.19M | -577.97M | -514.83M | -493.2M | -418.99M | -334.76M | -300.94M | -277.58M | -252.08M | -225.95M | -200.17M | -176.71M | -150.71M | -133.37M | -101.31M | -63.43M | -34.86M | -17.17M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -118.32K | -78.86K | -104K | -88K | -88K | -92K | -121K | -8K | -3.14M | -2.97M | -2.76M | -2.62M | -2.43M | -2.24M | 0 | 692 | -1.57M | 0 | 12.99K | -41.67K | -66.48K | -87.53K |
| Minority Interest | 1.3M | 1.32M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Imminent liquidity exhaustion
As reported in recent financial statements, Vyome Holdings has seen its total assets contract from $10.7 million in 2023Q4 to $10.2 million in 2026Q1, while equity volatility remains extreme, reflecting a business model that is struggling to maintain a stable capital base amidst persistent operational losses.
The downward trend in total assets suggests that the company is consuming its resource base to fund ongoing clinical development without a corresponding replenishment of capital. This trajectory indicates that the firm's financial foundation is weakening, leaving little room for error in its research and development milestones.
Based on the most recent quarterly data, Vyome Holdings holds $8.8 million in cash, yet the company's historical burn rate suggests this buffer is insufficient to support long-term clinical operations, as evidenced by the rapid fluctuations in liquidity observed over the past ten quarters.
While the current ratio of 4.27 appears superficially healthy, it is heavily influenced by the timing of liabilities and does not account for the high cash burn inherent in the company's clinical-stage pipeline. Investors should monitor the cash-to-burn ratio closely, as the current liquidity position may necessitate dilutive financing in the near term.
According to historical balance sheet filings, Vyome Holdings' equity has experienced significant instability, including a period of negative equity in 2024Q4, which highlights the severe impact of accumulated deficits on the company's book value and overall financial health.
The erratic nature of the equity account, driven by massive retained earnings deficits, suggests that the company's capital structure is highly sensitive to operational performance. This volatility may indicate that the firm is reliant on external capital injections to maintain solvency, which poses a persistent risk to existing shareholders.
As indicated by the provided data, the inclusion of $314.2K in goodwill on the balance sheet warrants further investigation, as it may represent an overvaluation of intangible assets that could be subject to impairment if the company's clinical pipeline fails to achieve commercial viability.
The presence of goodwill in a company with such limited revenue and high operating losses suggests that the asset side of the balance sheet may be overstated. Analysts should consider the potential for future write-downs, which would further erode the company's already fragile equity position.
Quick answers to the most common questions about buying HIND stock.
As of 2025, Vyome Holdings, Inc. (HIND) had total assets of $6.5M including $5.4M in current assets.
Vyome Holdings, Inc. (HIND) carries total debt of $0.0M, offset by $5.0M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Vyome Holdings, Inc. (HIND) has total shareholders' equity (book value) of $2.4M ($1.74 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Vyome Holdings, Inc. (HIND) reported a current ratio of 1.99x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.